跳至主要内容
临床试验/NCT01306851
NCT01306851Unknown4 期

Multicenter, Randomized, Controlled, Single Blinded, Phase IV Study Comparing 2 Parallel Groups in the Evaluation of the Prevention of Anastomotic Leaks in GI High Risk Anastomosis, With or Without the Application of Fibrin Glue in the Anastomotic Line

Hospital General Universitario Gregorio Marañon1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2007年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
200
试验地点
1
主要终点
Occurence of anastomotic leak

研究概览

简要总结

The anastomotic leak is one of the most feared complications in abdominal surgery. Certain control methods have been described but the incidence of that complication remains high and is the first cause of mortality in operations where gut anastomosis are performed.

With the aim to prove that the use of fibrin glue in the gut anastomosis can improve gut cicatrization, the investigators started the recruitment of patients to that clinical trial in 2007 with the study hypothesis that patients with a gut anastomosis where fibrin glue was used, had less anastomotic leaks than that where the fibrin glue was not used.

The investigators have calculated the number of patients necessaries to have statistical significant differences in 200 patients with a rate anastomotic leak expected to be higher than 10%.

The study include all the patients that usually arrive to our surgery department and that are expected to have a high risk gut anastomosis: rectal anastomosis, GI anastomosis in the obese patient, small bowel anastomosis in the obstructed one and esophageal anastomosis.

The study is randomized, simple blind where the patient does not know if they are in the fibrin glue group or not, and prospectively analyzed. All the clinical and laboratory or radiographic finds relative to the occurrence of an anastomotic leak are recorded.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients undergoing GI surgery where a high risk anastomosis is preview to be done

排除标准

  • Haemodynamic instability
  • Advanced oncologic disease
  • Proteins below 4 gr/ml

研究组 & 干预措施

Fibrin glue

Active Comparator

干预措施: Fibrin glue (Drug)

结局指标

主要结局

Occurence of anastomotic leak

时间窗: 6 months

The occurence of anastomotic leak in the 6 months after the surgery is the most important factor to determine if fibrin glue is helpful in the prevention of that complicacion.

次要结局

  • Evidence of infectious collections in the anastomotic area(3 months)

研究者

发起方
Hospital General Universitario Gregorio Marañon
申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Prevention of Anastomotic Leak in Gastrointestinal... | 临床试验